FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma

Google Scholar: cites

(Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Kokkonen, S.M. (Oulu University Hospital (Finlàndia))
Kuittinen, O. (Kuopio University Hospital ( Finlàndia))
Sunela, K. (Tampere University Hospital)
Universitat Autònoma de Barcelona. Departament de Medicina

Data:	2022
Resum:	Aim: The purpose of the study was to evaluate the clinical impact of fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) followed by a new biopsy from the site with maximum standardized uptake value (SUVmax) in case of high maximal SUV values, in detecting clinically unsuspected histologic transformations (HT) of follicular lymphoma (FL). Methods: This retrospective study included all the patients who had undergone FDG-PET/CT during primary diagnosis or relapse of FL between 2010 and 2020 at Oulu University Hospital. Results: The diagnosis changed from an indolent disease to a transformed lymphoma in >10% (7/63) of the patients who underwent diagnostic FDG-PET/CT. The HT risk associated with high SUVmax (>10) was 24% (7 of 29 performed biopsies). Four out of these seven patients with verified HT had no previous clinical suspicion of transformation. Conclusion: Our results suggest that a rebiopsy based on a high SUVmax in diagnostic FDG-PET/CT is valuable in detecting clinically unsuspected HT of FL.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Publicat a:	Cancer Medicine, 2022 , ISSN 2045-7634

5 p, 423.3 KB

Registre creat el 2023-01-17, darrera modificació el 2024-07-01